Monica E. Luchi MD

Dr. Monica E. Luchi is the President and Chief Medical Officer for Immune Pharmaceuticals. She is a Board-certified rheumatologist with over 17 years of industry experience, at both large pharmaceutical and small biotech companies. Prior to joining Immune, Dr. Luchi held senior positions at Novartis, Incyte and Mesoblast, where she led cross-functional teams and drove strategy across all phases of clinical development in a variety of therapeutic areas including inflammation, dermatology, oncology and immunology. In addition, Dr. Luchi has been instrumental in driving business interests of the biotech companies where she worked in order to engage development partners and to strengthen financial assets which supported further progress of the companies’ development activities. She is adjunct Clinical Assistant Professor on faculty at the University of Pennsylvania where she completed her fellowship, and continues active patient care one half day per week. She has recently served on the Metro chapter board for the Healthcare Businesswoman’s Association. Dr. Luchi obtained undergraduate degrees in Biology and in Health Science Policy at the University of Maryland, Baltimore Co. Campus. She received her MD from Northeastern Ohio Universities, College of Medicine, and an MBA with a concentration in healthcare from George Washington University.